1
|
Lugarà M, Tamburrini S, Coppola MG, Oliva G, Fiorini V, Catalano M, Carbone R, Saturnino PP, Rosano N, Pesce A, Galiero R, Ferrara R, Iannuzzi M, Vincenzo D, Negro A, Somma F, Fasano F, Perrella A, Vitiello G, Sasso FC, Soldati G, Rinaldi L. The Role of Lung Ultrasound in SARS-CoV-19 Pneumonia Management. Diagnostics (Basel) 2022; 12:diagnostics12081856. [PMID: 36010207 PMCID: PMC9406504 DOI: 10.3390/diagnostics12081856] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2022] [Revised: 07/24/2022] [Accepted: 07/27/2022] [Indexed: 12/22/2022] Open
Abstract
Purpose: We aimed to assess the role of lung ultrasound (LUS) in the diagnosis and prognosis of SARS-CoV-2 pneumonia, by comparing it with High Resolution Computed Tomography (HRCT). Patients and methods: All consecutive patients with laboratory-confirmed SARS-CoV-2 infection and hospitalized in COVID Centers were enrolled. LUS and HRCT were carried out on all patients by expert operators within 48−72 h of admission. A four-level scoring system computed in 12 regions of the chest was used to categorize the ultrasound imaging, from 0 (absence of visible alterations with ultrasound) to 3 (large consolidation and cobbled pleural line). Likewise, a semi-quantitative scoring system was used for HRCT to estimate pulmonary involvement, from 0 (no involvement) to 5 (>75% involvement for each lobe). The total CT score was the sum of the individual lobar scores and ranged from 0 to 25. LUS scans were evaluated according to a dedicated scoring system. CT scans were assessed for typical findings of COVID-19 pneumonia (bilateral, multi-lobar lung infiltration, posterior peripheral ground glass opacities). Oxygen requirement and mortality were also recorded. Results: Ninety-nine patients were included in the study (male 68.7%, median age 71). 40.4% of patients required a Venturi mask and 25.3% required non-invasive ventilation (C-PAP/Bi-level). The overall mortality rate was 21.2% (median hospitalization 30 days). The median ultrasound thoracic score was 28 (IQR 20−36). For the CT evaluation, the mean score was 12.63 (SD 5.72), with most of the patients having LUS scores of 2 (59.6%). The bivariate correlation analysis displayed statistically significant and high positive correlations between both the CT and composite LUS scores and ventilation, lactates, COVID-19 phenotype, tachycardia, dyspnea, and mortality. Moreover, the most relevant and clinically important inverse proportionality in terms of P/F, i.e., a decrease in P/F levels, was indicative of higher LUS/CT scores. Inverse proportionality P/F levels and LUS and TC scores were evaluated by univariate analysis, with a P/F−TC score correlation coefficient of −0.762, p < 0.001, and a P/F−LUS score correlation coefficient of −0.689, p < 0.001. Conclusions: LUS and HRCT show a synergistic role in the diagnosis and disease severity evaluation of COVID-19.
Collapse
Affiliation(s)
- Marina Lugarà
- U.O.C. Internal Medicine, ASL Center Naples 1, P.O. Ospedale del Mare, 80147 Naples, Italy; (M.G.C.); (G.O.)
- Correspondence:
| | - Stefania Tamburrini
- U.O.C. Radiology, ASL Center Naples 1, P.O. Ospedale del Mare, 80147 Naples, Italy; (S.T.); (V.F.); (M.C.); (R.C.); (P.P.S.); (N.R.); (A.P.)
| | - Maria Gabriella Coppola
- U.O.C. Internal Medicine, ASL Center Naples 1, P.O. Ospedale del Mare, 80147 Naples, Italy; (M.G.C.); (G.O.)
| | - Gabriella Oliva
- U.O.C. Internal Medicine, ASL Center Naples 1, P.O. Ospedale del Mare, 80147 Naples, Italy; (M.G.C.); (G.O.)
| | - Valeria Fiorini
- U.O.C. Radiology, ASL Center Naples 1, P.O. Ospedale del Mare, 80147 Naples, Italy; (S.T.); (V.F.); (M.C.); (R.C.); (P.P.S.); (N.R.); (A.P.)
| | - Marco Catalano
- U.O.C. Radiology, ASL Center Naples 1, P.O. Ospedale del Mare, 80147 Naples, Italy; (S.T.); (V.F.); (M.C.); (R.C.); (P.P.S.); (N.R.); (A.P.)
| | - Roberto Carbone
- U.O.C. Radiology, ASL Center Naples 1, P.O. Ospedale del Mare, 80147 Naples, Italy; (S.T.); (V.F.); (M.C.); (R.C.); (P.P.S.); (N.R.); (A.P.)
| | - Pietro Paolo Saturnino
- U.O.C. Radiology, ASL Center Naples 1, P.O. Ospedale del Mare, 80147 Naples, Italy; (S.T.); (V.F.); (M.C.); (R.C.); (P.P.S.); (N.R.); (A.P.)
| | - Nicola Rosano
- U.O.C. Radiology, ASL Center Naples 1, P.O. Ospedale del Mare, 80147 Naples, Italy; (S.T.); (V.F.); (M.C.); (R.C.); (P.P.S.); (N.R.); (A.P.)
| | - Antonella Pesce
- U.O.C. Radiology, ASL Center Naples 1, P.O. Ospedale del Mare, 80147 Naples, Italy; (S.T.); (V.F.); (M.C.); (R.C.); (P.P.S.); (N.R.); (A.P.)
| | - Raffaele Galiero
- Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, 80121 Naples, Italy; (R.G.); (R.F.); (F.C.S.); (L.R.)
| | - Roberta Ferrara
- Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, 80121 Naples, Italy; (R.G.); (R.F.); (F.C.S.); (L.R.)
| | - Michele Iannuzzi
- Department of Anesthesia and Intensive care Medicine, ASL Center Naples 1, P.O. Ospedale del Mare, 80147 Naples, Italy;
| | - D’Agostino Vincenzo
- U.O.C. Neurodiology, ASL Center Naples 1, P.O. Ospedale del Mare, 80147 Naples, Italy; (D.V.); (A.N.); (F.S.); (F.F.)
| | - Alberto Negro
- U.O.C. Neurodiology, ASL Center Naples 1, P.O. Ospedale del Mare, 80147 Naples, Italy; (D.V.); (A.N.); (F.S.); (F.F.)
| | - Francesco Somma
- U.O.C. Neurodiology, ASL Center Naples 1, P.O. Ospedale del Mare, 80147 Naples, Italy; (D.V.); (A.N.); (F.S.); (F.F.)
| | - Fabrizio Fasano
- U.O.C. Neurodiology, ASL Center Naples 1, P.O. Ospedale del Mare, 80147 Naples, Italy; (D.V.); (A.N.); (F.S.); (F.F.)
| | - Alessandro Perrella
- Infectious Diseases at Health Direction, AORN A. Cardarelli, 80131 Naples, Italy;
| | - Giuseppe Vitiello
- Healt Direction, ASL Center Naples 1, P.O. Ospedale del Mare, 80147 Naples, Italy;
| | - Ferdinando Carlo Sasso
- Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, 80121 Naples, Italy; (R.G.); (R.F.); (F.C.S.); (L.R.)
| | - Gino Soldati
- Diagnostic and Interventional Ultrasound Unit, Valle del Serchio General Hospital, Castelnuovo Garfagnana, 55032 Lucca, Italy;
| | - Luca Rinaldi
- Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, 80121 Naples, Italy; (R.G.); (R.F.); (F.C.S.); (L.R.)
| |
Collapse
|
2
|
Urso DL, Vincenzo D, Pignataro E, Acri P, Cucinotta G. Diagnosis and treatment of refractory asthma. Eur Rev Med Pharmacol Sci 2008; 12:315-320. [PMID: 19024216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
Asthma is an inflammatory disorder of the airway associated with airflow obstruction and bronchial hyperresponsiveness that varies in severity across the spectrum of the disease. Asthma affects 5-7% of the population of North America and Europe, and the prevalence is increasing. Most patients with asthma are easily diagnosed, responding to standard treatment with a short-acting inhaled beta2-agonists for symptom control, and to long-term therapy to including inhaled glucocorticosteroids to control airway inflammation. However a subgroup of patients with asthma (likely approximately 10%) have more troublesome disease reflected by high medication requirements to maintain good disease control or persistent symptoms, asthma exacerbations, or airflow obstruction despite high medication use. A term to describe this subgroup of asthmatic patients is "Refractory Asthma". Patients with difficult to control asthma require a rigorous and systematic approach to their diagnosis and treatment. It is critical to make a diagnosis of asthma and to exclude other airways diseases and to identify whether there are any correctable factors that may contribute to their poor control. Another poor adherence to therapy is common reason for a poor response. Treatment involves optimizing corticosteroid inhaled therapy, assesing additional controllers, such as inhaled beta2-agonist, leukotriene inhibitors, anti-immunoglobulins (Ig), oral corticosteroids and sustained-release theophylline.
Collapse
Affiliation(s)
- D L Urso
- Emergency Department, V Cosentino Hospital, Cariati Marina, Cosenza, Italy.
| | | | | | | | | |
Collapse
|